Phase 4 Multiple Sclerosis Trial, Not Yet Recruiting NCT07240649 Sponsor: Jay C. Buckey Jr. Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Phase 4 Multiple Sclerosis Trial, Not Yet Recruiting

NCT07240649
Not Yet Recruiting Phase 4

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been referred for hyperbaric oxygen therapy (a treatment involving breathing pure oxygen in a pressurised chamber) for a condition that is a newer or emerging use of this therapy.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have certain medical conditions that make hyperbaric oxygen therapy unsafe, including untreated seizures, a collapsed lung (pneumothorax), certain lung conditions that could be worsened by pressure changes, severe claustrophobia that cannot be managed, or a lung condition called COPD where carbon dioxide builds up in the body.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 August 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Jay Buckey, Dartmouth-Hichcock Medical Center

Phone: 540-819-5715

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 4
Sponsor
Jay C. Buckey Jr.
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
1 December 2035

Primary endpoints

Quality of Life EuroQOL EQ-5D-5L Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov